haloperidol and exenatide

haloperidol has been researched along with exenatide in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K1
Daniels, JS; Days, EL; Gentry, PR; Jones, CK; Lindsley, CW; Locuson, CW; Morris, LC; Morrison, RD; Nance, KD; Niswender, CM; Niswender, KD; Thompson, AD; Weaver, CD1

Reviews

1 review(s) available for haloperidol and exenatide

ArticleYear
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
    Drug discovery today, 2016, Volume: 21, Issue:4

    Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk

2016

Other Studies

1 other study(ies) available for haloperidol and exenatide

ArticleYear
Discovery of (S)-2-cyclopentyl-N-((1-isopropylpyrrolidin2-yl)-9-methyl-1-oxo-2,9-dihydro-1H-pyrrido[3,4-b]indole-4-carboxamide (VU0453379): a novel, CNS penetrant glucagon-like peptide 1 receptor (GLP-1R) positive allosteric modulator (PAM).
    Journal of medicinal chemistry, 2014, Dec-11, Volume: 57, Issue:23

    Topics: Allosteric Regulation; Animals; Catalepsy; Central Nervous System Agents; Drug Synergism; Exenatide; Glucagon-Like Peptide 1; Glucagon-Like Peptide-1 Receptor; Haloperidol; High-Throughput Screening Assays; Indoles; Insulin; Insulin Secretion; Islets of Langerhans; Male; Mice, Inbred C57BL; Microsomes, Liver; Peptides; Pyrrolidines; Receptors, Glucagon; Structure-Activity Relationship; Venoms

2014